We are live on ! Find out more
BIA

Bell Investment Advisors Portfolio holdings

AUM $681M
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+18.36%
3 Year Est. Return
+41.03%
5 Year Est. Return
10 Year Est. Return
AUM
$487M
AUM Growth
+$41M
Cap. Flow
+$5.44M
Cap. Flow %
1.12%
Top 10 Hldgs %
58.81%
Holding
2,039
New
116
Increased
658
Reduced
715
Closed
130
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMFG icon
1801
Sumitomo Mitsui Financial
SMFG
$164B
$543 ﹤0.01%
56
-63
-53% -$611
YORW icon
1802
York Water
YORW
$514M
$541 ﹤0.01%
+14
New +$527
ENVX icon
1803
Enovix
ENVX
$1.03B
$539 ﹤0.01%
49
-239
-83% -$2.35K
RNST icon
1804
Renasant Corp
RNST
$3.91B
$539 ﹤0.01%
16
NVCR icon
1805
NovoCure
NVCR
$1.91B
$538 ﹤0.01%
36
+21
+140% +$281
UDR icon
1806
UDR
UDR
$12.3B
$537 ﹤0.01%
14
-51
-78% -$1.77K
ULCC icon
1807
Frontier Group Holdings
ULCC
$1.7B
$536 ﹤0.01%
+98
New +$429
SUI icon
1808
Sun Communities
SUI
$14.7B
$535 ﹤0.01%
4
-8
-67% -$964
CACC icon
1809
Credit Acceptance
CACC
$6.08B
$533 ﹤0.01%
+1
New +$450
CSGS
1810
DELISTED
CSG Systems International
CSGS
$533 ﹤0.01%
+10
New +$512
INGN icon
1811
Inogen
INGN
$164M
$533 ﹤0.01%
+97
New +$513
PRK icon
1812
Park National Corp
PRK
$3.67B
$532 ﹤0.01%
4
MAT icon
1813
Mattel
MAT
$4.23B
$529 ﹤0.01%
28
MRTX
1814
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$529 ﹤0.01%
+9
New +$506
RARE icon
1815
Ultragenyx Pharmaceutical
RARE
$2.55B
$527 ﹤0.01%
11
LITE icon
1816
Lumentum
LITE
$69.3B
$525 ﹤0.01%
10
-23
-70% -$1K
B
1817
DELISTED
Barnes Group Inc.
B
$523 ﹤0.01%
16
-32
-67% -$914
LAND
1818
Gladstone Land Corp
LAND
$360M
$521 ﹤0.01%
+36
New +$513
UNIT
1819
Uniti Group
UNIT
$2.32B
$521 ﹤0.01%
90
-38
-30% -$193
CAE icon
1820
CAE Inc. Common Shares
CAE
$8.74B
$519 ﹤0.01%
24
-34
-59% -$725
FBNC icon
1821
First Bancorp
FBNC
$2.68B
$519 ﹤0.01%
14
HKD
1822
AMTD Digital
HKD
$534M
$518 ﹤0.01%
124
+47
+61% +$214
ALLO icon
1823
Allogene Therapeutics
ALLO
$694M
$517 ﹤0.01%
+161
New +$457
HRMY icon
1824
Harmony Biosciences
HRMY
$2.24B
$517 ﹤0.01%
16
KMT icon
1825
Kennametal
KMT
$2.52B
$516 ﹤0.01%
+20
New +$482

Similar funds

Bell Investment Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Bell Investment Advisors held 2,039 positions worth $487M, up 9.2% from $446M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Bell Investment Advisors's Q4 2023 filing shows 116 new, 658 increased, 715 reduced and 130 closed positions. Its largest new stake was Fidelity MSCI Information Technology Index ETF: 1,447 shares worth $208K. The largest sale was Invesco S&P 500 Low Volatility ETF, an estimated $1.4M.

By sector, the portfolio is most concentrated in Technology at 2.6% of assets, up from 2.4% a quarter earlier, followed by Communication Services and Healthcare.

  • Bell Investment Advisors's largest Q4 2023 buy was Fidelity MSCI Information Technology Index ETF: 1,447 shares worth $208K.
  • Bell Investment Advisors added most to Schwab Fundamental US Large Company Index ETF in Q4 2023, an estimated $3.26M increase.
  • Bell Investment Advisors's biggest Q4 2023 reduction was Invesco S&P 500 Low Volatility ETF, cutting an estimated $1.4M.
  • Bell Investment Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $37.3K.
  • Bell Investment Advisors's ten largest holdings make up 59% of its $487M portfolio in Q4 2023.
  • Bell Investment Advisors opened 116 new positions and closed 130 in Q4 2023.
  • Bell Investment Advisors's portfolio value rose 9.2% quarter-over-quarter to $487M.

Based on Bell Investment Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.